# Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

> **NCT01112865** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 120 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DEVICE:** Genotropin Pen
- **DEVICE:** MARK VII pen
- **DEVICE:** Genotropin Pen
- **DEVICE:** MARK VII pen

## Key facts

- **NCT ID:** NCT01112865
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01112865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01112865, "Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01112865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*